nodes	percent_of_prediction	percent_of_DWPC	metapath
Difluprednate—NR3C1—urine—urinary bladder cancer	0.246	0.317	CbGeAlD
Difluprednate—NR3C1—prostate gland—urinary bladder cancer	0.0883	0.114	CbGeAlD
Difluprednate—NR3C1—seminal vesicle—urinary bladder cancer	0.0747	0.0963	CbGeAlD
Difluprednate—NR3C1—epithelium—urinary bladder cancer	0.0649	0.0837	CbGeAlD
Difluprednate—NR3C1—smooth muscle tissue—urinary bladder cancer	0.0625	0.0806	CbGeAlD
Difluprednate—NR3C1—renal system—urinary bladder cancer	0.0602	0.0776	CbGeAlD
Difluprednate—NR3C1—urethra—urinary bladder cancer	0.0591	0.0762	CbGeAlD
Difluprednate—NR3C1—female reproductive system—urinary bladder cancer	0.0482	0.0622	CbGeAlD
Difluprednate—NR3C1—vagina—urinary bladder cancer	0.0436	0.0562	CbGeAlD
Difluprednate—NR3C1—lymph node—urinary bladder cancer	0.0282	0.0364	CbGeAlD
Difluprednate—NR3C1—Endoderm Differentiation—BPTF—urinary bladder cancer	0.0253	0.113	CbGpPWpGaD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—HDAC4—urinary bladder cancer	0.0167	0.0745	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—KRT5—urinary bladder cancer	0.0114	0.051	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MT2A—urinary bladder cancer	0.00965	0.043	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.00819	0.0365	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—ESR2—urinary bladder cancer	0.00811	0.0361	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—urinary bladder cancer	0.00695	0.031	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.00641	0.0286	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—urinary bladder cancer	0.0064	0.0285	CbGpPWpGaD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—urinary bladder cancer	0.00492	0.0219	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—ESR1—urinary bladder cancer	0.00492	0.0219	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—NCOR1—urinary bladder cancer	0.00466	0.0208	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—PPARG—urinary bladder cancer	0.00449	0.02	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—urinary bladder cancer	0.0044	0.0196	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.00389	0.0173	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—TNF—urinary bladder cancer	0.00369	0.0164	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00355	0.0158	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.00342	0.0152	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—CREBBP—urinary bladder cancer	0.0033	0.0147	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—CREBBP—urinary bladder cancer	0.00321	0.0143	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.00321	0.0143	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—ESR1—urinary bladder cancer	0.00302	0.0134	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—urinary bladder cancer	0.003	0.0134	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.0027	0.012	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.00268	0.012	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.00262	0.0117	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.00235	0.0105	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—NCOR1—urinary bladder cancer	0.00234	0.0104	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—urinary bladder cancer	0.00233	0.0104	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.00232	0.0103	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.00225	0.01	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.00219	0.00975	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—EP300—urinary bladder cancer	0.00218	0.00973	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.0021	0.00936	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—FAS—urinary bladder cancer	0.0021	0.00935	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.00201	0.00894	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.00196	0.00872	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.0019	0.00846	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.00189	0.00842	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—urinary bladder cancer	0.00185	0.00825	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.0018	0.00803	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IL2—urinary bladder cancer	0.00177	0.00788	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.00168	0.0075	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PPARG—urinary bladder cancer	0.00168	0.00748	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—urinary bladder cancer	0.00167	0.00743	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—RB1—urinary bladder cancer	0.00161	0.00715	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.0016	0.00714	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IGF1—urinary bladder cancer	0.00159	0.00709	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—EP300—urinary bladder cancer	0.00159	0.00707	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.00157	0.00699	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.0014	0.00622	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.00139	0.00621	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.00129	0.00574	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—CDKN1A—urinary bladder cancer	0.00115	0.00514	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—TP53—urinary bladder cancer	0.00114	0.00506	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.00111	0.00493	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.00111	0.00493	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000949	0.00423	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TNF—urinary bladder cancer	0.000891	0.00397	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000855	0.00381	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.00077	0.00343	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000671	0.00299	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000613	0.00273	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SMC1A—urinary bladder cancer	0.000612	0.00273	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000588	0.00262	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ESR2—urinary bladder cancer	0.000533	0.00238	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NCOR1—urinary bladder cancer	0.000412	0.00183	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ERCC2—urinary bladder cancer	0.000387	0.00172	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000349	0.00156	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ESR1—urinary bladder cancer	0.000323	0.00144	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PPARG—urinary bladder cancer	0.000295	0.00131	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—CREBBP—urinary bladder cancer	0.000283	0.00126	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—MYC—urinary bladder cancer	0.000168	0.000749	CbGpPWpGaD
